In conclusion, we identified that the number of CD68+ TAMs in TN of KT tissues is an independent risk factor affecting OS in patients with CRC or GC combined with KTs, whereas tumor resection range might be an independent risk factor affecting PFS in patients (Table 3). The gene discussed is CD68; the disease is gastric cancer.